Evaluation of the Effect of the Dietary Supplement X34 on Skin Radiance of Healthy Volunteers With Dull Complexion

NCT ID: NCT02347969

Last Updated: 2016-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this trial is to evaluate the effect of the daily dose of X34 dietary supplement on skin radiance (clinical assessment) for 8 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

X34

Arm supplemented with X34

Group Type EXPERIMENTAL

X34

Intervention Type DIETARY_SUPPLEMENT

Dietary supplement named X34

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

X34

Dietary supplement named X34

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female volunteers:
* Age: 40-70 years
* Who have a dull complexion evaluated by clinical scoring
* Phototype II to IV (annex 5)
* Non-smoking or smoking less than 5 cigarettes per day
* Did not change her eating habits, within one month before the start of the study and agreeing not change during the study
* With no history of facial skin care (peeling, mask…) 15 days before the beginning of the study and agreeing not to perform during the study
* Volunteers accepting not changing their local treatment on face
* Who agree to avoid UV exposure (sun or tanning booth) during the study
* Who have a fixed address and are entitled to Social Security or a similar National Insurance scheme
* Who sign a written informed consent

Exclusion Criteria

* Pregnant, nursing, or intending to become pregnant in the course of the study
* With a history of allergy or hypersensitivity to the products or one of their components
* Having use oral nutritional supplements and/or vitamin supplementation less than one month before and/or refusing not consuming nutritional supplement during the study
* Having used cosmetics and/or topical preparations containing ingredients claiming efficacy on skin radiance less than 15 days before and/or during the study
* With a dermatosis, systemic disease or treatment susceptible to interfere with the evolution of the parameters of the study or with taking the nutritional supplement
* Participation in another clinical trial evaluating skin radiance during the last month before the study
* Participation in another clinical trial or volunteers being in the exclusion phase of such a trial, thus being unable to participate in any other one
* Who have forfeited their freedom by judiciary decision or are deemed legally incompetent
* Having perceived more than 4500 € as indemnification fees for participation in clinical trials during the preceding 12 months (including participation in this clinical trial)
* Unable to comply with the protocol constraints
* Who cannot be contacted by phone rapidly
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Research and Studies Center on the Integument (CERT)

UNKNOWN

Sponsor Role collaborator

University of Franche-Comté

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role collaborator

Clinical Investigation Center (CIC) INSERM 1431

UNKNOWN

Sponsor Role collaborator

INSERM UMR1098

UNKNOWN

Sponsor Role collaborator

Nutratech Conseils

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DE-87

Identifier Type: -

Identifier Source: org_study_id

NCT02352415

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bioavailability of Astaxanthin Formulations
NCT03443882 UNKNOWN EARLY_PHASE1